BioVectra

Adapting, Partnering, and Innovating: Insights from CPhI Frankfurt

How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.

Agilent to Buy Canadian CDMO Biovectra for $925 Million

Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I.G. Capital in a move to expand its end-to-end biopharma solutions.

Mallinckrodt Sells BioVectra to H.I.G. Capital